机构:[1]School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, China[2]Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA[3]Center for Intelligent Drug Delivery and Sensing Using Microcontainers and Nanomechanics (IDUN), Department of Health Technology, Technical University of Denmark (DTU), 2800 Kgs. Lyngby, Denmark[4]The First Affiliated Hospital, Department of Chemistry, Jinan University, Guangzhou 510632, China[5]Orthopedics Department, Guangdong Provincial Hospital of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China广东省中医院[6]School of Material Science and Engineering, Zhengzhou University, Zhengzhou, Henan 450001, China
Oral administration is perhaps the most commonly used and acceptable route for drug delivery to patients, mainly due to its non-invasiveness, simplicity, and versatility. Conventional delivery media such as tablets or capsule-based formulations, however, could result in low drug bioavailability and insufficient therapeutic efficiency, especially for delivering biologics (e.g., peptide, protein, antibody, nucleic acid). Therefore, with the advancement of material science and micro-/nano-fabrication techniques, various carriers have been developed to protect drugs and improve their absorption in the gastrointestinal (GI) tract. Herein, we first summarized various types of drug molecules being used for oral administration. Then we discussed the major physiological barriers (including various biochem-ical, mucosal diffusion, and cellular permeation barriers) that hinder drug transportation and absorption, as well as the main targeting regions in the GI tract. On this basis, we reviewed recently emerged oral drug delivery platforms and discussed their widely investigated biomedical applications. Finally, we present future perspectives for materials science-enabled oral drug delivery platforms, and potential challenges for clinical translation.
基金:
Harvard Medical School/Brigham and Women's Hospital Department of Anesthesiology-Basic Scientist Grant [2420 BPA075]; Center for Nanomedicine Research Fund [2019A014810]; Gillian Reny Stepping Strong Center for Trauma Innovation Breakthrough Innovator Award [113548]; Nanotechnology Foundation [2022A002721]; Farokhzad Family Distinguished Chair Foundation; Khoury Innovation Award [2020A003219]; American Heart Association (AHA) Collaborative Sciences Award [2018A004190]; Guangdong Basic and Applied Basic Research Foundation [2022A1515011766]
第一作者机构:[1]School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 511436, China[2]Center for Nanomedicine and Department of Anesthesiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Ouyang Jiang,Zhang Zhongyang,Deng Bo,et al.Oral drug delivery platforms for biomedical applications[J].MATERIALS TODAY.2023,62:296-326.doi:10.1016/j.mattod.2023.01.002.
APA:
Ouyang, Jiang,Zhang, Zhongyang,Deng, Bo,Liu, Jinggong,Wang, Liqiang...&Tao, Wei.(2023).Oral drug delivery platforms for biomedical applications.MATERIALS TODAY,62,
MLA:
Ouyang, Jiang,et al."Oral drug delivery platforms for biomedical applications".MATERIALS TODAY 62.(2023):296-326